Condition: Air Pollution · Cardiometabolic Health · Sponsor: University of Southern California
The goal of this randomized, double-blind, crossover trial is to test the hypothesis that a longer-term indoor HEPA filtration intervention can improve cardiometabolic profiles by reducing indoor PM2.5 exposures in at-risk individuals.
This description comes directly from the study's public registry record.
Zhanghua Chen, PhD · 323-442-2109 · zhanghuc@usc.edu
Junfeng Zhang, PhD · 919-681-7782 · junfeng.zhang@duke.edu
Always discuss trial participation with your own doctor first.
| Keck School of Medicine, University of Southern California | Los Angeles, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05718245